Search Results - "Connolly, S. J."

Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis by Miller, S, Crystal, E, Garfinkle, M, Lau, C, Lashevsky, I, Connolly, S J

“…Objectives: To assess the efficacy of the administration of magnesium as a method for the prevention of postoperative atrial fibrillation (AF) and to evaluate…”
Get full text

Assessing the impact of dabigatran and warfarin on health-related quality of life: Results from an RE-LY sub-study by Monz, B.U, Connolly, S.J, Korhonen, M, Noack, H, Pooley, J

“…Abstract Background Anticoagulation is recommended in patients with atrial fibrillation (AF) to prevent strokes. Vitamin K antagonists, such as warfarin, are…”
Get full text

Evidence-based analysis of amiodarone efficacy and safety by CONNOLLY, S. J

Get full text

Canadian implantable defibrillator study (CIDS) : A randomized trial of the implantable cardioverter defibrillator against amiodarone by CONNOLLY, S. J, GENT, M, ROBERTS, R. S, DORIAN, P, ROY, D, SHELDON, R. S, MITCHELL, L. B, GREEN, M. S, KLEIN, G. J, O'BRIEN, B

“…Patients surviving ventricular fibrillation (VF) or sustained ventricular tachycardia (VT) are at a high risk of death due to a recurrence of arrhythmia. The…”
Get full text

Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials by Connolly, S. J., Hallstrom, A. P., Cappato, R., Schron, E. B., Kuck, K.-H., Zipes, D. P., Greene, H. L., Boczor, S., Domanski, M., Follmann, D., Gent, M., Roberts, R. S.

“…Aims Three randomized trials of implantable cardioverter defibrillator (ICD) therapy vs medical treatment for the prevention of death in survivors of…”
Get full text

Effect of a simple two‐step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study by KIM, Y.‐K., NIEUWLAAT, R., CONNOLLY, S. J., SCHULMAN, S., MEIJER, K., RAJU, N., KAATZ, S., EIKELBOOM, J. W.

“…Background: The efficacy and safety of vitamin K antagonists for the prevention of thromboembolism are dependent on the time for which the International…”
Get full text

Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation by Huber, K, Connolly, S J, Kher, A, Christory, F, Dan, G-A, Hatala, R, Kiss, R G, Meier, B, Merkely, B, Pieske, B, Potpara, T, Stępińska, J, Klun, N Vene, Vinereanu, D, Widimský, P

“…Atrial fibrillation (AF) is associated with an increased risk of thromboembolism, and is the most prevalent factor for cardioembolic stroke. Vitamin K…”
Get more information

Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES by Vanassche, Thomas, Lauw, Mandy N, Eikelboom, John W, Healey, Jeff S, Hart, Robert G, Alings, Marco, Avezum, Alvaro, Díaz, Rafael, Hohnloser, Stefan H, Lewis, Basil S, Shestakovska, Olga, Wang, Jia, Connolly, Stuart J

“…The pattern of atrial fibrillation (AF) occurrence-paroxysmal, persistent, or permanent-is associated with progressive stages of atrial dysfunction and…”
Get full text

Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non‐valvular atrial fibrillation from the RE‐LY trial by LIESENFELD, K.‐H., LEHR, T., DANSIRIKUL, C., REILLY, P. A., CONNOLLY, S. J., EZEKOWITZ, M. D., YUSUF, S., WALLENTIN, L., HAERTTER, S., STAAB, A.

“…Background: Dabigatran etexilate (DE) is an orally absorbed prodrug of dabigatran, a thrombin inhibitor that exerts potent anticoagulant and antithrombotic…”
Get full text

Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add? by Fox, K A A, Eikelboom, J W, Anand, S S, Bhatt, D L, Bosch, J, Connolly, S J, Harrington, R A, Steg, P G, Yusuf, S

Get full text

Dual-chamber versus ventricular pacing : Critical appraisal of current data by CONNOLLY, S. J, KERR, C, GENT, M, YUSUF, S

Get full text

Canadian atrial fibrillation anticoagulation (CAFA) study by CONNOLLY, S. J, LAUPACIS, A, GENT, M, ROBERTS, R. S, CAIRNS, J. A, JOYNER, C

“…The Canadian Atrial Fibrillation Anticoagulation Study was a randomized double-blind placebo-controlled trial to assess the potential of warfarin to reduce…”
Get full text

Metoprolol prophylaxis against postoperative atrial fibrillation increases length of hospital stay in patients not on pre-operative β blockers: the β blocker length of stay (BLOS) trial by Crystal, E, Thorpe, K E, Connolly, S J, Lamy, A, Cybulsky, I, Carroll, S, Roberts, R, Gent, M

Get full text

Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE‐LY trial by Proietti, M., Hijazi, Z., Andersson, U., Connolly, S. J., Eikelboom, J. W., Ezekowitz, M. D., Lane, D. A., Oldgren, J., Roldan, V., Yusuf, S., Wallentin, L.

“…Background Oral anticoagulation is the mainstay of stroke prevention in atrial fibrillation (AF), but must be balanced against the associated bleeding risk…”
Get full text

Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE‐LY trial by Westenbrink, B. D., Alings, M., Connolly, S. J., Eikelboom, J., Ezekowitz, M. D., Oldgren, J., Yang, S., Pongue, J., Yusuf, S., Wallentin, L., Gilst, W. H.

“…Summary Background Anemia may predispose to thromboembolic events or bleeding in anticoagulated patients with atrial fibrillation (AF). Objectives To…”
Get full text

Atrial pacing periablation for prevention of paroxysmal atrial fibrillation by GILLIS, A. M, WYSE, D. G, CONNOLLY, S. J, DUBUC, M, PHILIPPON, F, YEE, R, LACOMBE, P, ROSE, S, KERR, C. D

“…This study tested the hypothesis that rate-adaptive atrial pacing would prevent paroxysmal atrial fibrillation (PAF) in patients with frequent PAF in the…”
Get full text

Nonrheumatic atrial fibrillation : risk of stroke and role of antithrombotic therapy by CAIRNS, J. A, CONNOLLY, S. J

Get full text

Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation by Connolly, Stuart J, Pogue, Janice, Hart, Robert G, Hohnloser, Stefan H, Pfeffer, Marc, Chrolavicius, Susan, Yusuf, Salim

“…A randomized trial enrolled 7554 patients with atrial fibrillation who were at increased risk of stroke but not candidates for vitamin K antagonists…”
Get full text

Defibrillation Testing at the Time of ICD Insertion: An Analysis From the Ontario ICD Registry by HEALEY, J. S., BIRNIE, D. H., LEE, D. S., Krahn, A. D., Crystal, E., Simpson, C. S., Dorian, P., Chen, Z., Cameron, D., Verma, A., Connolly, S. J., Gula, L. J., Lockwood, E., Nair, G., Tu, J. V.

“…Defibrillation Testing at the Time of ICD Insertion. Background: Increasingly, ICD implantation is performed without defibrillation testing (DT). Objectives:…”
Get full text

Dabigatran efficacy‐safety assessment for stroke prevention in patients with atrial fibrillation by EIKELBOOM, J. W., QUINLAN, D. J., CONNOLLY, S. J., HART, R. G., YUSUF, S.

Get full text